Uncategorized
Elon Musk Says Orbital Nvidia Computers Launch Next Year — Can SpaceX Actually Pull It Off?
calendar_month Sep 14, 2026, BY Erica Kollmann
Uncategorized
Ondas Adds Critical Weapons Tech In $205 Million Deal
calendar_month Sep 14, 2026, BY Lekha Gupta
Uncategorized
Why Is Summit Therapeutics Stock Gaining Monday?
calendar_month Sep 14, 2026 BY Vandana Singh
Uncategorized
What’s Happening With Zscaler Stock Today?
calendar_month Sep 14, 2026 BY Henry Khederian
Microsoft’s New AI Safety Rules Trigger Surge in 3 Cybersecurity Stocks

Microsoft Corp’s (NASDAQ:MSFT) new AI safety framework is already getting a vote from Wall Street. By 11:30 a.m. ET Monday, CrowdStrike Holdings, Inc. (NASDAQ:CRWD) shares had surged 14.7%, Palo Alto Networks, Inc. (NASDAQ:PANW) was up more than 12.7% and Cloudflare,…

Uncategorized , calendar_month Sep 14, 2026
Nvidia’s Customer Concentration Problem: CFO Says ‘We Get Paid Twice’

Nvidia Corp‘s (NASDAQ:NVDA) AI revenue comes from just a handful of buyers. CFO Colette Kress hopes to turn that customer concentration risk into recurring revenue by getting paid once for GPUs and again when they generate compute income. Three direct…

Uncategorized, calendar_month Sep 14, 2026
What’s Going On With Monolithic Power Systems Stock Monday?

Monolithic Power Systems Inc. (NASDAQ:MPWR) stock fell nearly 7% Monday as semiconductor and high-valuation technology stocks came under pressure. The Nasdaq fell 0.82%, while the S&P 500 lost 0.39%. Technology was the worst-performing sector, down 1.7%. Monolithic Power’s decline came…

Uncategorized, calendar_month Sep 14, 2026
Anthropic’s AI Warning Is ‘Noise’ in a ‘Secular Bull Market:’ Bank of America Says

Every artificial intelligence company may want the race to slow down. None can afford to be the first to stop running.That is Bank of America’s answer to Monday’s AI-driven sell-off. • NVIDIA stock is facing resistance. What’s driving NVDA stock…

Uncategorized, calendar_month Sep 14, 2026
Why Is GSK Stock Gaining Monday?

On Monday, GSK plc (NYSE:GSK) stock is trading higher on highly positive clinical data from two separate lung cancer trials, demonstrating significant efficacy and survival benefits across different patient populations. Strong Survival Rates In Small Cell Lung Cancer In partnership…